C09DA04 |
B |
Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg |
10873 |
27322/1 |
CO APROVEL |
|
28 |
Tablet, film coated |
Oral |
Mersaco |
Sanofi Winthrop Industrie |
France |
658,483 L.L |
23.08 |
A1 |
Sanofi Aventis Groupe |
France |
04/03/20 |
|
C09DA04 |
B |
Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg |
11904 |
128523/1 |
CO APROVEL |
|
28 |
Tablet, film coated |
Oral |
Mersaco |
Sanofi Winthrop Industrie |
France |
658,483 L.L |
23.08 |
A1 |
Sanofi Winthrop Industrie |
France |
04/03/20 |
|
C09DA04 |
G |
Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg |
7386 |
185988/13 |
ANDARAN PLUS |
|
28 |
Tablet, film coated |
Oral |
Khalil Fattal & Fils S.A.L. |
Pharmaline (Packing) under license from Sandoz, Austria |
Lebanon |
544,586 L.L |
23.08 |
A1 |
|
|
04/03/20 |
|
C09DA04 |
G |
Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg |
10529 |
130417/1 |
CONVERIUM PLUS |
|
30 |
Tablet, film coated |
Oral |
New Allpharma |
Medochemie Ltd |
Cyprus |
395,090 L.L |
23.08 |
A1 |
Medochemie Ltd |
Cyprus |
04/03/20 |
|
C09DA04 |
G |
Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg |
7676 |
30714/1 |
GIZLAN-PLUS |
|
30 |
Tablet, film coated |
Oral |
Sadco |
Dar Al Dawa Development & Investment Co Ltd |
Jordan |
395,090 L.L |
23.08 |
A1 |
Dar Al Dawa Development & Investment Co Ltd |
Jordan |
04/03/20 |
|
C09DA04 |
G |
Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg |
8513 |
185802/13 |
IBECARD PLUS 300/12.5 |
|
30 |
Tablet, film coated |
Oral |
IPS "Integrated Pharma Solutions SARL" |
Benta SAL |
Lebanon |
559,294 L.L |
23.08 |
A1 |
|
|
04/03/20 |
|
C09DA04 |
G |
Irbesartan - 300mg, Hydrochlorothiazide - 12.5mg |
6225 |
167547/10 |
ZIOREL PLUS |
|
30 |
Tablet, film coated |
Oral |
Droguerie de l'Union |
Algorithm S.A.L. |
Lebanon |
559,294 L.L |
23.08 |
A1 |
|
|
04/03/20 |
|